Kapbro Pharma Private Limited
About Kapbro Pharma Private Limited
Data last updated:
Kapbro Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2005PTC134804. Its GSTIN is 07AACCK6073A1ZV (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹30.15 Lakh. It is led by directors including Prem Nath Kapoor and Arun Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at O – 46 First Floor Lajpat Nagar – II, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2024, the company reported a revenue of ₹149.03 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹1.07 Cr (net margin 0.7%) and EBITDA of ₹3.51 Cr (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 28% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kapbro Pharma. As per MCA filings, the company has open charges of ₹30.54 Cr and satisfied charges of ₹5.75 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressO – 46 First Floor Lajpat Nagar – II, New Delhi, Delhi, India – 110024
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kapbro Pharma Private Limited
The main business activity of Kapbro Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kapbro Pharma Private Limited FY 2024 filings available
Kapbro Pharma Private Limited reported revenue of ₹149.03 Cr (up 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Kapbro Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 32% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kapbro Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.51 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kapbro Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kapbro Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kapbro Pharma Private Limited
Kapbro Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amistad Pharmachem Private Limited | ₹153.04 Cr (FY 2024) | •••• | •••• | 121.0% | •••• | Mumbai, Maharashtra, India |
| S C Paul and Wholesale Private Limited | ₹151.86 Cr (FY 2025) | •••• | •••• | •••• | Serampore, West Bengal, India | |
| Grifols India Healthcare Private Limited | ₹151.68 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Gurgaon, Haryana, India |
| Amvigor Organics Private Limited | ₹151.34 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Mumbai, Maharashtra, India |
| R S R Resource Enterprises Private Limited | ₹151.01 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Kapbro Pharma Private Limited this company | ₹149.03 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
| Famy Pharma Private Limited | ₹148.42 Cr (FY 2025) | •••• | •••• | 72.0% | •••• | Ahmedabad, Gujarat, India |
| Caritas Healthcare Private Limited | ₹146.85 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Ahmedabad, Gujarat, India |
| Sidhaant Life Sciences Private Limited | ₹146.4 Cr (FY 2025) | •••• | •••• | 71.0% | •••• | New Delhi, Delhi, India |
| N.R. Pharmaceuticals Private Limited | ₹144.8 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Kolkata, West Bengal, India |
| Sinkhai Healthcare Limited | ₹144.67 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Kapbro Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kapbro Pharma Private Limited
Kapbro Pharma Private Limited is audited by SEKHRI & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SEKHRI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kapbro Pharma Private Limited
Kapbro Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prem Nath Kapoor Also directs: Ridhwik Enterprises LLP | Director | 07 Apr 2005 | 21 Years 6 Months | Current |
| Arun Kapoor Also directs: Lifemate India Private Limited | Director | 07 Apr 2005 | 21 Years 6 Months | Current |
| Renu Kapoor | Director | 07 Apr 2005 | 21 Years 6 Months | Current |
| Manish Kapoor Also directs: Ridhwik Enterprises LLP | Director | 16 Dec 2022 | 3 Years 9 Months | Current |
Ownership and Shareholding of Kapbro Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kapbro Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2025 | Others | ₹20 Lakh | Open |
| 28 Aug 2023 | Hdfc Bank Limited | ₹34.28 Lakh | Open |
| 10 Dec 2018 | Others | ₹30 Cr | Open |
| 16 Jun 2016 | Yes Bank Limited | ₹2 Cr | Satisfied |
| 17 Feb 2011 | Indian Overseas Bank | ₹3 Cr | Satisfied |
Total charge records: 7 View all charges
Legal Cases of Kapbro Pharma Private Limited
Kapbro Pharma Private Limited has 1 court case on record: 1 filed by Kapbro Pharma. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Kapbro Pharma Private Limited
Kapbro Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 101 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Kapbro Pharma Private Limited
Kapbro Pharma operates one associated brand: Kapbro Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients. | kapbropharma.com |
Employees and EPFO Compliance at Kapbro Pharma Private Limited
Kapbro Pharma Private Limited has a workforce of 26 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kapbro Pharma Private Limited
Kapbro Pharma Private Limited has 5 board changes on record since 2005: 4 appointments and 1 cessation. The latest: Saroj Kapoor ceased to be Director on 27 Mar 2024.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Kapbro Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kapbro Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kapbro Pharma Private Limited
Kapbro Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCK6073A1ZV | Delhi | Active | 01 Jul 2017 |
| 05AACCK6073A1ZZ | Uttarakhand | Active | 27 Dec 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kapbro Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kapbro Pharma Private Limited
Kapbro Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 April 2005 (21+ years old) and is registered under CIN U24233DL2005PTC134804.
Kapbro Pharma reported revenue of ₹149.03 Cr for FY 2024 (up 32% YoY).
Kapbro Pharma has 4 current directors:
- Prem Nath Kapoor - Director
- Arun Kapoor - Director
- Renu Kapoor - Director
- Manish Kapoor - Director
Kapbro Pharma reported a net profit of ₹1.07 Cr (net margin 0.7%) and EBITDA of ₹3.51 Cr (EBITDA margin 2.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kapbro Pharma is 46% over three years and 28% over five years. In the latest year (FY 2024) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kapbro Pharma is 07AACCK6073A1ZV, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AACCK6073A1ZZ (Uttarakhand).
The CIN (Corporate Identification Number) of Kapbro Pharma is U24233DL2005PTC134804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kapbro Pharma has 1 court case on record: 1 filed by the company.
Kapbro Pharma was incorporated on 07 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kapbro Pharma by revenue are Amistad Pharmachem Private Limited, S C Paul and Wholesale Private Limited, Grifols India Healthcare Private Limited, Amvigor Organics Private Limited, R S R Resource Enterprises Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Saroj Kapoor ceased to be Director on 27 Mar 2024. Manish Kapoor was appointed as Director on 16 Dec 2022. Arun Kapoor was appointed as Director on 07 Apr 2005. Kapbro Pharma has 5 board changes on record in total.
Kapbro Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 101 overdue payments to 1 micro and small supplier. The latest return was filed on 30 May 2019.